Impact of dietary fat on gut microbiota and low-grade systemic inflammation: mechanisms and clinical implications on obesity

References

• Abbasi F, Blasey C, Reaven GM. 2013. Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am J Clin Nutr. 98:637–640.
   PubMed Web of Science ®Google Scholar
• Abdullah A, Peeters A, de Courten M, Stoelwinder J. 2010. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 89:309–319.
   PubMed Web of Science ®Google Scholar
• Alex S, Lichtenstein L, Dijk W, Mensink RP, Tan NS, Kersten S. 2014. ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol. 141:383–391.
   PubMed Web of Science ®Google Scholar
• An HM, Park SY, Lee DK, Kim JR, Cha MK, Lee SW, Lim HT, Kim KJ, Ha NJ. 2011. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis. 10:116.
   PubMed Web of Science ®Google Scholar
• Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC. 2010. Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol. 10:1–11.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. 2004. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 101:15718–15723.
   PubMed Web of Science ®Google Scholar
• Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA. 104:979–984.
   PubMed Web of Science ®Google Scholar
• Belzer C, de Vos WM. 2012. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 6:1449–1458.
   PubMed Web of Science ®Google Scholar
• Berg RD. 1996. The indigenous gastrointestinal microflora. Trends Microbiol. 4:430–435.
   PubMed Web of Science ®Google Scholar
• Bergman EN. 1990. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 70:567–590.
   PubMed Web of Science ®Google Scholar
• Blaut M, Klaus S. 2012. Intestinal microbiota and obesity. Handb Exp Pharmacol. 251–273.
   PubMedGoogle Scholar
• Bogunovic M, Davé SH, Tilstra JS, Chang DTW, Harpaz N, Xiong H, Mayer LF, Plevy SE. 2007. Enteroendocrine cells express functional Toll-like receptors. Am J Physiol Gastrointest Liver Physiol. 292:G1770–G1783.
   PubMed Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani M, Palù G, Martines D. 2007. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol. 292:G518–G525.
   PubMed Web of Science ®Google Scholar
• Caesar R, Nygren H, Orešič M, Bäckhed F. 2016. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. J Lipid Res. 57:474–481.
   PubMed Web of Science ®Google Scholar
• Calder PC. 2013. n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions. Proc Nutr Soc. 72:326–336.
   PubMed Web of Science ®Google Scholar
• Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, et al. 2007. Metabolic Endotoxemia Initiates obesity and insulin resistance. Diabetes. 56:1761–1772.
   PubMed Web of Science ®Google Scholar
• Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R. 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 57:1470–1481.
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. 2007. Gut microflora as a target for energy and metabolic homeostasis. Curr Opin Clin Nutr Metab Care. 10:729–734.
   PubMed Web of Science ®Google Scholar
• Cani PD, Delzenne NM. 2011. The gut microbiome as therapeutic target. Pharmacol Ther. 130:202–212.
   PubMed Web of Science ®Google Scholar
• Cani PD, Geurts L, Matamoros S, Plovier H, Duparc T. 2014. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab. 40:246–257.
   PubMed Web of Science ®Google Scholar
• Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O, Geurts L, Naslain D, Neyrinck A, Lambert DM, et al. 2009. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 58:1091–1103.
   PubMed Web of Science ®Google Scholar
• Cano PG, Santacruz A, Trejo FM, Sanz Y. 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity (Silver Spring). 21:2310–2321.
   PubMed Web of Science ®Google Scholar
• Collado MC, Isolauri E, Laitinen K, Salminen S. 2008. Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am J Clin Nutr. 88:894–899.
   PubMed Web of Science ®Google Scholar
• Cotillard A, Kennedy SP, Kong LC, Prifti E, Pons N, Le Chatelier E, Almeida M, Quinquis B, Levenez F, Galleron N, et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature. 500:585–588.
   PubMed Web of Science ®Google Scholar
• Daniel H, Gholami AM, Berry D, Desmarchelier C, Hahne H, Loh G, Mondot S, Lepage P, Rothballer M, Walker A, et al. 2014. High-fat diet alters gut microbiota physiology in mice. ISME J. 8:295–308.
   PubMed Web of Science ®Google Scholar
• Davis CD. 2016. The gut microbiome and its role in obesity. Nutr Today. 51:167–174.
   PubMedGoogle Scholar
• de Heredia FP, Gómez-Martínez S, Marcos A. 2012. Obesity, inflammation and the immune system. Proc Nutr Soc. 71:332–338.
   PubMed Web of Science ®Google Scholar
• de La Serre CB, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. 2010. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. 299:G440–G448.
   PubMed Web of Science ®Google Scholar
• de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Muller M, van der Meer R, et al. 2012. Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine. AJP Gastrointest Liver Physiol. 303:G589–G599.
   PubMed Web of Science ®Google Scholar
• Derrien M, Vaughan EE, Plugge CM, de Vos WM. 2004. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 54:1469–1476.
   PubMed Web of Science ®Google Scholar
• Desbois AP, Lebl T, Yan L, Smith VJ. 2008. Isolation and structural characterisation of two antibacterial free fatty acids from the marine diatom, Phaeodactylum tricornutum. Appl Microbiol Biotechnol. 81:755–764.
   PubMed Web of Science ®Google Scholar
• Desbois AP, Smith VJ. 2010. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl Microbiol Biotechnol. 85:1629–1642.
   PubMed Web of Science ®Google Scholar
• Devkota S, Wang Y, Musch MW, Leone V, Fehlner-Peach H, Nadimpalli A, Antonopoulos DA, Jabri B, Chang EB. 2012. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10–/– mice. Nature. 487:104–108.
   PubMed Web of Science ®Google Scholar
• Dilzer A, Park Y. 2012. Implication of conjugated linoleic acid (CLA) in human health. Crit Rev Food Sci Nutr. 52:488–513.
   PubMed Web of Science ®Google Scholar
• Dorresteijn JN, Visseren FLJ, Spiering W. 2012. Mechanisms linking obesity to hypertension. Obes Rev. 13:17–26.
   PubMed Web of Science ®Google Scholar
• El Aidy S, Merrifield CA, Derrien M, van Baarlen P, Hooiveld G, Levenez F, Doré J, Dekker J, Holmes E, Claus SP, et al. 2013. The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation. Gut. 62:1306–1314.
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 110:9066–9071.
   PubMed Web of Science ®Google Scholar
• Everard A, Lazarevic V, Derrien M, Girard M, Muccioli GG, Muccioli GM, Neyrinck AM, Possemiers S, Van Holle A, François P, et al. 2011. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes. 60:2775–2786.
   PubMed Web of Science ®Google Scholar
• Feldlaufer MF, Knox DA, Lusby WR, Shimanuki H. 1993. Antimicrobial activity of fatty acids against Bacillus larvae, the causative agent of American foulbrood disease. Apidologie. 24:5.
   Web of Science ®Google Scholar
• Gabert L, Vors C, Louche-Pélissier C, Sauvinet V, Lambert-Porcheron S, Drai J, Laville M, Désage M, Michalski M-C. et al. 2011. 13C tracer recovery in human stools after digestion of a fat-rich meal labelled with [1,1,1-13C3]tripalmitin and [1,1,1-13C3]triolein. Rapid Commun Mass Spectrom RCM. 25:2697–2703.
   PubMed Web of Science ®Google Scholar
• Galbraith H, Miller TB, Paton AM, Thompson JK. 1971. Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol. J Appl Bacteriol. 34:803–813.
   PubMedGoogle Scholar
• Geurts L, Lazarevic V, Derrien M, Everard A, Van Roye M, Knauf C, Valet P, Girard M, Muccioli GG, François P, et al. 2011. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol. 2:149.
   PubMed Web of Science ®Google Scholar
• Ghoshal S, Witta J, Zhong J, de Villiers W, Eckhardt E. 2009. Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res. 50:90–97.
   PubMed Web of Science ®Google Scholar
• Gómez Candela C, Bermejo López LM, Loria Kohen V. 2011. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health: nutritional recommendations. Nutr Hosp. 26:323–329.
   PubMed Web of Science ®Google Scholar
• Guerciolini R. 1997. Mode of action of orlistat. Int J Obes Relat Metab Disord. 21 Suppl 3:S12–S23.
   PubMed Web of Science ®Google Scholar
• Harvey AE, Lashinger LM, Hursting SD. 2011. The growing challenge of obesity and cancer: an inflammatory issue. Ann N Y Acad Sci. 1229:45–52.
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, et al. 2012. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 482:179–185.
   PubMed Web of Science ®Google Scholar
• Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, Keilbaugh SA, Hamady M, Chen Y-Y, Knight R, Ahima RS, Bushman F, Wu GD, et al. 2009. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 137:1716–1724.
   PubMed Web of Science ®Google Scholar
• Honda KL. 2014. Effect of omega-3 fatty acids on toll-like receptor 4-mediated macrophage inflammation and its regulation. Tufts University.
   Google Scholar
• Huang CB, George B, Ebersole JL. 2010. Antimicrobial activity of n-6, n-7 and n-9 fatty acids and their esters for oral microorganisms. Arch Oral Biol. 55:555–560.
   PubMed Web of Science ®Google Scholar
• Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW, Adams SH, Hwang DH. 2012. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res. 53:2002–2013.
   PubMed Web of Science ®Google Scholar
• Hulston CJ, Churnside AA, Venables MC. 2015. Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr. 113:596–602.
   PubMed Web of Science ®Google Scholar
• Jayasinghe TN, Chiavaroli V, Holland DJ, Cutfield WS, O’sullivan JM. 2016. The new era of treatment for obesity and metabolic disorders: evidence and expectations for gut microbiome transplantation. Front Cell Infect Microbiol. 6:15.
   PubMed Web of Science ®Google Scholar
• Ji Y, Sakata Y, Tso P. 2011. Nutrient-induced inflammation in the intestine. Curr Opin Clin Nutr Metab Care. 14:315–321.
   PubMed Web of Science ®Google Scholar
• Karimi G, Sabran MR, Jamaluddin R, Parvaneh K, Mohtarrudin N, Ahmad Z, Khazaai H, Khodavandi A. 2015. The anti-obesity effects of Lactobacillus casei strain Shirota versus Orlistat on high fat diet-induced obese rats. Food Nutr Res. 59:29273.
   PubMed Web of Science ®Google Scholar
• Karlsson CLJ, Onnerfält J, Xu J, Molin G, Ahrné S, Thorngren-Jerneck K. 2012. The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring). 20:2257–2261.
   PubMed Web of Science ®Google Scholar
• Krajmalnik-Brown R, Ilhan Z-E, Kang D-W, DiBaise JK. 2012. Effects of gut microbes on nutrient absorption and energy regulation. Nutr. Clin Pract. 27:201–214.
   PubMed Web of Science ®Google Scholar
• Kübeck R, Bonet-Ripoll C, Hoffmann C, Walker A, Müller VM, Schüppel VL, Lagkouvardos I, Scholz B, Engel K-H, Daniel H, et al. 2016. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol Metab. 5:1162–1174.
   PubMed Web of Science ®Google Scholar
• Laugerette F, Vors C, Géloën A, Chauvin M-A, Soulage C, Lambert-Porcheron S, Peretti N, Alligier M, Burcelin R, Laville M, et al. 2011. Emulsified lipids increase endotoxemia: possible role in early postprandial low-grade inflammation. J Nutr Biochem. 22:53–59.
   PubMed Web of Science ®Google Scholar
• Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto J-M, Kennedy S, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature. 500:541–546.
   PubMed Web of Science ®Google Scholar
• Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. 102:11070–11075.
   PubMed Web of Science ®Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Microbial ecology: human gut microbes associated with obesity. Nature. 444:1022–1023.
   PubMed Web of Science ®Google Scholar
• Lichtenstein L, Mattijssen F, de Wit NJ, Georgiadi A, Hooiveld GJ, van der Meer R, He Y, Qi L, Koster A, Tamsma JT, et al. 2010. Angptl4 protects against severe pro-inflammatory effects of dietary saturated fat by inhibiting lipoprotein lipase-dependent uptake of fatty acids in mesenteric lymph node macrophages. Cell Metab. 12:580–592.
   PubMed Web of Science ®Google Scholar
• Ma J, Prince AL, Bader D, Hu M, Ganu R, Baquero K, Blundell P, Alan Harris R, Frias AE, Grove KL, et al. 2014. High-fat maternal diet during pregnancy persistently alters the offspring microbiome in a primate model. Nat Commun. 5:3889.
   PubMed Web of Science ®Google Scholar
• Marques TM, Wall R, O’sullivan O, Fitzgerald GF, Shanahan F, Quigley EM, Cotter PD, Cryan JF, Dinan TG, Ross RP, et al. 2015. Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. Br J Nutr. 113:728–738.
   PubMed Web of Science ®Google Scholar
• Martín-Peláez S, Mosele JI, Pizarro N, Farràs M, de la Torre R, Subirana I, Pérez-Cano FJ, Castañer O, Solà R, Fernandez-Castillejo S, et al. 2015. Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota. Eur J Nutr.
   Web of Science ®Google Scholar
• Mattijssen F, Alex S, Swarts HJ, Groen AK, van Schothorst EM, Kersten S. 2014. Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion. Mol Metab. 3:135–144.
   PubMed Web of Science ®Google Scholar
• Moreira APB, Texeira TFS, Ferreira AB, do Carmo Gouveia Peluzio M, de Cássia Gonçalves Alfenas R. 2012. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr. 108:801–809.
   PubMed Web of Science ®Google Scholar
• Mowat AM, Agace WW. 2014. Regional specialization within the intestinal immune system. Nat Rev Immunol. 14:667–685.
   PubMed Web of Science ®Google Scholar
• Muccioli GG, Naslain D, Bäckhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. 2010. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol. 6:392.
   PubMed Web of Science ®Google Scholar
• Mujico JR, Baccan GC, Gheorghe A, Díaz LE, Marcos A. 2013. Changes in gut microbiota due to supplemented fatty acids in diet-induced obese mice. Br J Nutr. 110:711–720.
   PubMed Web of Science ®Google Scholar
• Murphy EF, Cotter PD, Healy S, Marques TM, O’sullivan O, Fouhy F, Clarke SF, O'Toole PW, Quigley EM, Stanton C, et al. 2010. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 59:1635–1642.
   PubMed Web of Science ®Google Scholar
• Naidu AS, Bidlack WR, Clemens RA. 1999. Probiotic spectra of lactic acid bacteria (LAB). Crit Rev Food Sci Nutr. 39:13–126.
   PubMed Web of Science ®Google Scholar
• Núñez IN, Galdeano CM, de LeBlanc A, de M, Perdigón G. 2014. Evaluation of immune response, microbiota, and blood markers after probiotic bacteria administration in obese mice induced by a high-fat diet. Nutrition. 30:1423–1432.
   PubMed Web of Science ®Google Scholar
• Olefsky JM, Glass CK. 2010. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 72:219–246.
   PubMed Web of Science ®Google Scholar
• Osterberg KL, Boutagy NE, McMillan RP, Stevens JR, Frisard MI, Kavanaugh JW, Davy BM, Davy KP, Hulver MW. 2015. Probiotic supplementation attenuates increases in body mass and fat mass during high-fat diet in healthy young adults. Obesity (Silver Spring). 23:2364–2370.
   PubMed Web of Science ®Google Scholar
• Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. 2006. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev. 27:73–100.
   PubMed Web of Science ®Google Scholar
• Patterson E, O’ Doherty RM, Murphy EF, Wall R, O’ Sullivan O, Nilaweera K, Fitzgerald GF, Cotter PD, Ross RP, Stanton C, et al. 2014. Impact of dietary fatty acids on metabolic activity and host intestinal microbiota composition in C57BL/6J mice. Br J Nutr. 111:1–13.
   PubMed Web of Science ®Google Scholar
• Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, McGuckin MA, Florin THJ. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol. 105:2420–2428.
   PubMed Web of Science ®Google Scholar
• Praveen Raj P, Gomes RM, Kumar S, Senthilnathan P, Karthikeyan P, Shankar A, Palanivelu C. 2015. The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: “NASHOST” prospective observational trial. Surg Obes Relat Dis. 11:1315–1322.
   PubMed Web of Science ®Google Scholar
• Prince A, Ma J, Baquero K, Blundell P, Takahashi D, Grove K, Aagaard K. 2016. Probiotics alter the intestinal microbiome but do not prevent high fat diet dysbiosis in primates. Am J Obstet Gynecol. 214:S44.
   Web of Science ®Google Scholar
• Qiao Y, Sun J, Xia S, Li L, Li Y, Wang P, Shi Y, Le G. 2015. Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model. J Funct Foods. 14:424–434.
   Web of Science ®Google Scholar
• Raso GM, Simeoli R, Iacono A, Santoro A, Amero P, Paciello O, Russo R, D’Agostino G, Di Costanzo M, Canani RB, et al. 2014. Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem. 25:81–90.
   PubMed Web of Science ®Google Scholar
• Remely M, Hippe B, Geretschlaeger I, Stegmayer S, Hoefinger I, Haslberger A. 2015. Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr. 127:394–398.
   PubMed Web of Science ®Google Scholar
• Rey FE, Gonzalez MD, Cheng J, Wu M, Ahern PP, Gordon JI. 2013. Metabolic niche of a prominent sulfate-reducing human gut bacterium. Proc Natl Acad Sci USA. 110:13582–13587.
   PubMed Web of Science ®Google Scholar
• Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, De los Reyes-Gavilán CG, Salazar N. 2016. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 7:185.
   PubMed Web of Science ®Google Scholar
• Russell DA, Ross RP, Fitzgerald GF, Stanton C. 2011. Metabolic activities and probiotic potential of bifidobacteria. Int J Food Microbiol. 149:88–105.
   PubMed Web of Science ®Google Scholar
• Salonen A, de Vos WM. 2014. Impact of diet on human intestinal microbiota and health. Annu Rev Food Sci Technol. 5:239–262.
   PubMed Web of Science ®Google Scholar
• Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C, et al. 2010. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 104:83–92.
   PubMed Web of Science ®Google Scholar
• Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 116:3015–3025.
   PubMed Web of Science ®Google Scholar
• Simões CD, Maukonen J, Kaprio J, Rissanen A, Pietiläinen KH, Saarela M. 2013. Habitual dietary intake is associated with stool microbiota composition in monozygotic twins. J Nutr. 143:417–423.
   PubMed Web of Science ®Google Scholar
• Song M, Park S, Lee H, Min B, Jung S, Park S, Kim E, Oh S. 2015. Effect of Lactobacillus acidophilus NS1 on plasma cholesterol levels in diet-induced obese mice. J Dairy Sci. 98:1492–1501.
   PubMed Web of Science ®Google Scholar
• Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y. 2007. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun. 354:45–49.
   PubMed Web of Science ®Google Scholar
• Suganami T, Tanimoto-Koyama K, Nishida J, Itoh M, Yuan X, Mizuarai S, Kotani H, Yamaoka S, Miyake K, Aoe S, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol. 27:84–91.
   PubMed Web of Science ®Google Scholar
• Sun CQ, O’connor CJ, Roberton AM. 2003. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol. 36:9–17.
   PubMed Web of Science ®Google Scholar
• Sun J, Qiao Y, Qi C, Jiang W, Xiao H, Shi Y, Le G-W. 2016. High-fat-diet-induced obesity is associated with decreased antiinflammatory Lactobacillus reuteri sensitive to oxidative stress in mouse Peyer’s patches. Nutrition. 32:265–272.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Hara H. 2010. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond). 7:19.
   PubMed Web of Science ®Google Scholar
• Swidsinski A, Loening-Baucke V, Theissig F, Engelhardt H, Bengmark S, Koch S, Lochs H, Dörffel Y. 2007. Comparative study of the intestinal mucus barrier in normal and inflamed colon. Gut. 56:343–350.
   PubMed Web of Science ®Google Scholar
• Tabas I, Glass CK. 2013. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 339:166–172.
   PubMed Web of Science ®Google Scholar
• Tagliabue A, Elli M. 2013. The role of gut microbiota in human obesity: recent findings and future perspectives. Nutr Metab Cardiovasc Dis NMCD. 23:160–168.
   PubMed Web of Science ®Google Scholar
• Tappy L. 2004. Metabolic consequences of overfeeding in humans. Curr Opin Clin Nutr Metab Care. 7:623–628.
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Bäckhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature. 489:242–249.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 3:213–223.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al. 2009. A core gut microbiome in obese and lean twins. Nature. 457:480–484.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444:1027–1131.
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 1:6ra14.
   PubMed Web of Science ®Google Scholar
• Wall R, Ross RP, Fitzgerald GF, Stanton C. 2010. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev. 68:280–289.
   PubMed Web of Science ®Google Scholar
• Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, van-Hylckama Vlieg JET, Strissel K, Zhao L, Obin M, et al. 2015. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J. 9:1–15.
   PubMed Web of Science ®Google Scholar
• Weglarz L, Dzierzewicz Z, Skop B, Orchel A, Parfiniewicz B, Wiśniowska B, Swiatkowska L, Wilczok T. 2003. Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. Cell Mol Biol Lett. 8:991–1003.
   PubMed Web of Science ®Google Scholar
• Weingarden A, González A, Vázquez-Baeza Y, Weiss S, Humphry G, Berg-Lyons D, Knights D, Unno T, Bobr A, Kang J, et al. 2015. Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection. Microbiome. 3:10.
   PubMed Web of Science ®Google Scholar
• Wille JJ, Kydonieus A. 2003. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol. 16:176–187.
   PubMedGoogle Scholar
• Wu C-C, Weng W-L, Lai W-L, Tsai H-P, Liu W-H, Lee M-H, Tsai Y-C. 2015. Effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice, effect of Lactobacillus plantarum strain K21 on high-fat diet-fed obese mice. Evid Based Complement Altern Med. 2015:e391767.
   PubMed Web of Science ®Google Scholar
• Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, et al. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science. 334:105–108.
   PubMed Web of Science ®Google Scholar
• Yin Y-N, Yu Q-F, Fu N, Liu X-W, Lu F-G. 2010. Effects of four Bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol. 16:3394–3401.
   PubMed Web of Science ®Google Scholar
• Yoo J, Kim S. 2016. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. 8:173.
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang M, Wang S, Han R, Cao Y, Hua W, Mao Y, Zhang X, Pang X, Wei C, et al. 2010. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 4:232–241.
   PubMed Web of Science ®Google Scholar
• Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, et al. 2009. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA. 106:2365–2370.
   PubMed Web of Science ®Google Scholar
• Zheng CJ, Yoo J-S, Lee T-G, Cho H-Y, Kim Y-H, Kim W-G. 2005. Fatty acid synthesis is a target for antibacterial activity of unsaturated fatty acids. FEBS Lett. 579:5157–5162.
   PubMed Web of Science ®Google Scholar
• Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ, et al. 2008. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 295:E1160–E1166.
   PubMed Web of Science ®Google Scholar